Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOBI Podhaler Usability Study in Cystic Fibrosis
NCT02178540Phase 4Completed
- Sponsor
- Novartis
- Start
- Aug 2014
- Primary completion
- Feb 2015
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial, sponsored by Novartis. Primary endpoint: The Use of the Approved US TOBI Podhaler Instructions for Use (IFU) to Communicate the Information Necessary to Achieve Safe and Effective Use of the Podhaler Device at 1 day. Started Aug 2014; status: completed.
Beyond the preview
Go deeper on NCT02178540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02178540.